Zydus Cadila, first Indian Company gets permission for clinical trials of antibodies cocktail to treat COVID-19: Sources

The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been given permission to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO), according to sources.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fRbnIW
via IFTTT